Increased regional P2X7R expression detected by GSK1482160 PET in a tauopathy mouse model
Kong, Y.; Cao, L.; Wang, J.; Zhuang, J.; Liu, Y.; Bi, L.; Qiu, Y.; Hou, Y.; Huang, Q.; Xie, F.; Yang, Y.; Shi, K.; Rominger, A.; Guan, Y.; Jin, H.; Ni, R.
Show abstract
Neuroinflammation plays an important role in Alzheimers disease and primary tauopathies. The aim of the current study was to map [18F]GSK1482160 for imaging of purinergic P2X7R in Alzheimers disease and primary tauopathy mouse models. MicroPET was performed using [18F]GSK1482160 in widely used mouse models of Alzheimers disease (APP/PS1, 5xFAD and 3xTg), 4-repeat tauopathy (rTg4510) mice and age-matched wild-type mice. Increased uptake of [18F]GSK1482160 was observed in the cortex and basal forebrain of 7-month-old rTg4510 mice compared to age-matched wild-type mice and compared to 3-month-old rTg4510 mice. Nonparametric Spearmans rank analysis revealed a positive correlation between tau [18F]APN-1607 uptake and [18F]GSK1482160 in the hippocampus of rTg4510 mice. No significant differences in the uptake of [18F]GSK1482160 were observed between wild-type mice and APP/PS1 mice (5, 10 months), 5xFAD mice (3, 7 months) or 3xTg mice (10 months). Immunofluorescence staining further indicated the distribution of P2X7Rs in the brains of 7-month-old rTg4510 mice with accumulation of tau inclusion compared to wild-type mice. These findings provide in vivo imaging evidence for increased P2X7R in the brains of tauopathy model mice.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography 92%
- Synthesis and preclinical evaluation of MTP38 as a novel PET ligand for phophodiesterase 7 in the brain 92%
- Preclinical evaluation of the novel CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease 92%
Similar papers in this journal
- Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study 95%
- A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease 94%
- TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline 93%
Similar papers in this journal
- Voluntary running does not increase capillary blood flow but promotes neurogenesis and short-term memory in the APP/PS1 mouse model of Alzheimers disease 93%
- ACE1 Does Not Influence Cerebral Aβ Degradation or Amyloid Plaque Accumulation in 5XFAD Mice 93%
- Age-related changes in Tau and Autophagy in human brain in the absence of neurodegeneration 92%
Similar papers in this journal
- An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18 F-PM-PBB3 ( 18 F-APN-1607) 95%
- Time between milestone events in the Alzheimer's disease amyloid cascade 92%
- Cerebral grey matter density is associated with neuroreceptor and neurotransporter availability: A combined PET and MRI study 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.